Core Points - The company held its first meeting of the fourth board of directors on June 4, 2025, where all directors unanimously agreed to waive the notice period for the meeting [1] - Chen Yinlong was elected as the chairman of the fourth board of directors, with a unanimous vote of 7 in favor [1] - The board also elected members for various specialized committees, with Chen Yinlong serving as the convener of the strategic committee and other members appointed accordingly [2] - Wu Shujing was appointed as the general manager of the company, with a unanimous vote of 7 in favor [3] - Four individuals, including Chen Yujie and Ye Chunsheng, were appointed as deputy general managers, also with a unanimous vote of 7 in favor [4] - Yu Miaomiao was appointed as the financial officer, receiving unanimous support from the board [4] - Fei Qijun was appointed as the secretary of the board, with unanimous approval [5] - Huang Yufeng was appointed as the securities affairs representative, also with unanimous support from the board [5]
博拓生物: 博拓生物第四届董事会第一次会议决议公告
